Skip to main content
Guru Sonpavde, MD, Oncology, Orlando, FL

GuruPSonpavdeMD

Oncology Orlando, FL

Genitourinary Oncology

GU Oncology & Phase I Director AdventHealth Cancer Institute University of Central Florida Orlando, FL, USA

Dr. Sonpavde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sonpavde's full profile

Already have an account?

  • Office

    AdventHealth Cancer Institute
    2501 N Orange Ave, Ste 681
    Orlando, FL 32804
    Phone+1 407-303-2024
    Fax+1 407-303-2038
  • Is this information wrong?

Summary

  • Current and Emerging Agents to Treat Advanced Bladder Cancer

    Current and Emerging Agents to Treat Advanced Bladder Cancer

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelia

    A New Prognostic Model for Post-Platinum PD-L1 Inhibitors Treatment of Urothelial Carcinoma

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

    Immunotherapy Outcomes in Pure vs Mixed Urothelial Carcinoma Histology

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
  • Nassau University Medical Center
    Nassau University Medical CenterResidency, Internal Medicine, 1992 - 1995
  • Christian Medical College Vellore
    Christian Medical College VelloreClass of 1990

Certifications & Licensure

  • CT State Medical License
    CT State Medical License Current
  • FL State Medical License
    FL State Medical License 2022 - 2024
  • MA State Medical License
    MA State Medical License 2017 - 2024
  • RI State Medical License
    RI State Medical License 2020 - 2020
  • AL State Medical License
    AL State Medical License 2012 - 2017
  • TX State Medical License
    TX State Medical License 2003 - 2013
  • AZ State Medical License
    AZ State Medical License 2001 - 2003
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer  
    G Sonpavde, C S Higano, T M Beer, Annals of Oncology
  • Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
    Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
  • Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.  
    Sonpavde G, Pond GR, Fougeray R, Bellmunt J., BJU Int, 2014

Lectures

  • 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder ... 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging AdvancesFebruary 2023
  • GU Updates Abound at ASCO 2021June 2021
  • Cancer treatment: is a clinical trial right for youMarch 2019
  • Immunotherapy for cancer therapy: What you need to knowJanuary 2019
  • Join now to see all

Press Mentions

  • New Approaches in the Bladder-Sparing Paradigm
    New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
  • Immune Checkpoint Inhibitors for Patients Living with HIV: Safe and Effective in Metastatic NSCLC
    Immune Checkpoint Inhibitors for Patients Living with HIV: Safe and Effective in Metastatic NSCLCNovember 11th, 2022
  • GU Updates Abound at ASCO 2021
    GU Updates Abound at ASCO 2021June 14th, 2021

Professional Memberships